Synthetic Biology company for targeted antimicrobials and microbiome editing.
Eligo Bioscience was created in 2014 based on the research from the Lu Lab (MIT) and the Marraffini Lab (Rockefeller University), which was later published in Nature Biotechnology.
Eligo was incubated at the Institut Pasteur in Paris from 2014 to 2017 and has moved in 2017 into the biotech cluster “Paris Biotech Santé” in the Cochin Hospital..
Visit website: https://eligo.bio/
People at Eligo Bioscience
Eligo Bioscience News
Synthetic Nanobots Could End Antibiotic Resistance
Futurism - 17-Nov-2017
Most current antibiotics wipe out all bacteria - good and bad. French startup Eligo Bioscience i...Read more...
Funding to build biological nanorobots
Silicon Republic - 28-Sep-2017
Founded in 2014, France-based Eligo Bioscience has received $20m Series A funding. Aims is to tr...Read more...